ACAD vs HOOD · P/E 15, rev $576.0M vs P/E 48, rev $2.38B
ACADIA Pharmaceuticals Inc (ACAD) versus Robinhood Markets Inc (HOOD) — a side-by-side from cached financials, not a winner call.
ACADIA Pharmaceuticals Inc (ACAD) is a biotechnology company listed on US.
Robinhood Markets Inc (HOOD) is a capital markets company listed on NASDAQ. It is led by Vlad Tenev.
Latest reported ACAD revenue for 2026-06-30 was $576.0M. Net income was $35.1M. ACAD currently screens at market cap $3.51B and trailing P/E 15.3.
Latest reported HOOD revenue for 2026-06-30 was $2.38B. Net income was $911.0M. HOOD currently screens at market cap $88.36B and trailing P/E 47.6.
ACAD currently screens at market cap $3.51B and trailing P/E 15.3. HOOD currently screens at market cap $88.36B and trailing P/E 47.6.
Not investment advice. Open the ACAD and HOOD stock pages for the full models.
Not investment advice.